| 吕晋红,李晓丽.益生菌辅助治疗重症急性胰腺炎的研究进展[J].安徽医药,2024,28(2):217-220. |
| 益生菌辅助治疗重症急性胰腺炎的研究进展 |
| Research progress of probiotics adjuvant therapy in severe acute pancreatitis |
| |
| DOI：10.3969/j.issn.1009-6469.2024.02.002 |
| 中文关键词: 胰腺炎，急性坏死性 益生菌 机制 有效性 安全性 |
| 英文关键词: Pancreatitis,acute necrotizing Probiotics Mechanism Effectivenes Security |
| 基金项目: |
|
| 摘要点击次数: 700 |
| 全文下载次数: 330 |
| 中文摘要: |
| 重症急性胰腺炎( SAP)是一种高发病率和高病死率的疾病，尽管对其治疗采用多方面的综合的支持治疗，但 SAP的病死率仍居高不下。近年来益生菌在临床上得到广泛应用，耐药性良好，而不良反应非常罕见。不少学者认为利用益生菌作为辅助药物应用到 SAP中具有重要意义，但其临床有效性及安全性尚存在争议，该文通过查阅相关文献，对益生菌辅助治疗 SAP的相关研究作一综述。 |
| 英文摘要: |
| Severe acute pancreatitis (SAP) is a disease with high incidence and mortality. Despite the comprehensive treatment, themortality of SAP is still high. In recent years, probiotics have been widely used in clinic, with good drug resistanceand rare adverse re.actions. Many scholars believe that the use of probiotics as adjuvant drugs in SAP is of great significance,but its clinical efficacy andsafety are still controversial. This paper summarizes the relevant literature on probiotics adjuvant therapy for SAP by consulting the rel.evant literature. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
